Serum lipase activity and concentration during intravenous infusions of GLP-1 and PYY3-36 and after ad libitum meal ingestion in overweight men.
To examine the effect on serum lipase activity and protein concentration of intravenous infusions of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY3-36) and of an ad libitum meal in healthy overweight men. Twenty-five healthy, male subjects participated in this randomized, double-blinded, placebo-controlled 4-arm crossover study (Body Mass Index (BMI): 29 ± 3 kg/m2, age: 33 ± 9 years). On separate days, the subjects received a 150-min intravenous infusion of either (1) 0.8 pmol/kg/min PYY3-36, (2) 1.0 pmol/kg/min GLP-1, (3) 1 + 2, or (4) placebo. Samples were collected throughout the infusion and after intake of an ad libitum meal for measurement of serum lipase. Serum lipase levels measured by enzyme-linked immunosorbent assay (ELISA) following mono-infusions of GLP-1 and PYY3-36were comparable to serum lipase levels following placebo (P = 0.054 and P = 0.873, respectively). Following the co-infusion of GLP-1 and PYY3-36, serum lipase levels measured by ELISA decreased over time compared to placebo (P = 0.012). However, the between-group difference was not consistent when each time point was analyzed separately. On the placebo day, serum lipase levels measured by ELISA after an ad libitum meal rose slightly compared to the preprandial values (P = 0.003). There was strong correlation between serum lipase levels measured by ELISA and LIPC Lipase colorimetric assay (COBAS) (0.94 < r; <0.0001). Infusions of GLP-1 and PYY3-36, separately or in combination, did not increase serum lipase. However, a small increase in serum lipase may occur in response to a meal.
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark jbs@nexs.ku.dk.
Julie B
JB
Schmidt
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Anders
A
Sjödin
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Lene S
LS
Stevner
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Christian
C
Ritz
Research Bioanalysis, Novo Nordisk A/S, Måløv, Denmark.
Natasha B
NB
Michaelsen
Medical & Science, GLP-1 & Obesity, Novo Nordisk A/S, Bagsvaerd, Denmark.
Anne B
AB
Thomsen
NNF Center for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Jens J
JJ
Holst
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Arne
A
Astrup
GLP‐1; PYY3‐36 and serum lipase
Physiol Rep. 2016 Sep;4(18):
27670407
Pancreatology. 2004;4(6):495-503; discussion 503-4
15316225
Obes Surg. 2012 Jul;22(7):1084-96
22359255
Ann Surg. 2007 Nov;246(5):780-5
17968169
Diabetes Care. 2012 Jul;35(7):1446-54
22584132
J Clin Endocrinol Metab. 2009 Dec;94(12):4679-87
19837930
Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1248-56
24735885
Mod Pathol. 2015 Mar;28(3):391-402
25216224
Diabetes. 2013 Sep;62(9):3044-52
23649520
Diabetes Care. 2009 May;32(5):834-8
19208917
Endocrinology. 2014 Apr;155(4):1280-90
24467746